Drug Type Small molecule drug |
Synonyms MK 0731 |
Target |
Action inhibitors |
Mechanism KIF11 inhibitors(Kinesin-like protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H28F3N3O2 |
InChIKeyMYBGWENAVMIGMM-GIFXNVAJSA-N |
CAS Registry845256-65-7 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | - | 01 May 2005 | |
| Solid tumor | Phase 1 | United States | - |
Phase 1 | 30 | uzltjxhjhb(vjdixowjgh) = vldktupryt kmjoxkzaej (lmgbignocb, ±7.3) View more | - | 01 Jun 2012 | |||
Phase 1 | 35 | imcpcgnlhy(criptpxjie) = ufmkyvnnae gioaaqkjqt (vtwjzgelnx ) View more | - | 20 Jun 2007 | |||
Phase 1 | 8 | qwmwwcvrnb(wmbtfvofng) = was observed in 2 pts at 48 mg/m2/24 hrs leading to expansion of cohorts at lower dose levels jvsmoretwt (vhbfwjrqur ) | - | 20 Jun 2006 |





